If so, check out these valuable resources: The new Goals Tracker at MyAFibExperience.org, where you will find downloadable PDFs to help you remember your medications, make better food choices, improve your physical activity, communicate more effectively with your healthcare provider, and track your progress. MyAFibExperience.org is a collaboration between the American Heart Association and StopAfib.org. …
Read More
Irregular or abnormal heart beats, called arrhythmias, occur when there are abnormal electrical impulses in your heart, causing your heart to beat too fast, too slow, or irregularly. Arrhythmias are very common and are often a mere annoyance, but they can also be responsible for life-threatening medical emergencies. The most common irregular heart rhythm is …
Read More
Get a special discount on the FDA-approved AfibAlert® heart monitor for detecting atrial fibrillation. Lohman Technologies is making this special $100 discount available for the StopAfib.org patient community for a limited time only, so please act quickly. To learn more, see: Special Discount on AfibAlert® Standalone Heart Monitor for Detecting Atrial Fibrillation.
Read More
EP Lab Digest recently published 2015 Get in Rhythm Patient Conference: Helping Afib Patients Get in Rhythm and Stay in Rhythm, authored by StopAfib.org founder Mellanie True Hills. The article talks about the previous successful inaugural Get in Rhythm, Stay in Rhythm Atrial Fibrillation Patient Conference, including what participants had to say. We have raised …
Read More
Are you joining us on March 28-29 in Dallas to learn from our world-renowned afib experts on how to get in rhythm and stay in rhythm? Afib patients are coming from all over to be here, and we hope you can join us, too. Learn more about the conference, and register, at: Afib Patients from …
Read More
Big news! Boehringer Ingelheim has submitted an application to the FDA requesting accelerated approval for idarucizumab, the reversal agent for Pradaxa (dabigatran). See: Boehringer Ingelheim Submits Biologics License Application to FDA for Idarucizumab*, Investigational Specific Reversal Agent for Pradaxa® Additionally, they have submitted for marketing approval by Health Canada and the European Medicines Agency (EMA). See: Boehringer …
Read More
Exciting News! AliveCor is giving away AliveCor® Heart Monitors to the first 100 people that enter and pick up their AliveCor at our Get in Rhythm, Stay in Rhythm AF Patient Conference! With conference early registration at ONLY $79, and the AliveCor Heart Monitor costing $75, this is pretty much a no-brainer! Register Today — …
Read More
Plan to join us March 28-29, 2015, at the StopAfib.org National Atrial Fibrillation Patient Conference to hear our rock-star cast of afib experts share ways for you to get in rhythm and stay in rhythm. This is a not-to-be-missed event—take a look at who’s speaking! The conference will be held at the Hyatt Regency DFW …
Read More